WIN 54954 (Standard)
WIN 54954 (Standard) is the analytical standard of WIN 54954. This product is intended for research and analytical applications. WIN 54954 is an orally active and broad-spectrum antipicornavirus agent. WIN 54954 is effectiveness against human rhinovirus, echovirus 9 and enterovirus infections.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 95%
- No. CAS: 107355-45-3
- Fòrmula: C18H20Cl2N2O3
- Peso molecular:383.27
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-13784
PirodavirPicornavirus Inhibitor -
HY-19952
PleconarilCapsid Inhibitor -
HY-106254
VapendavirEnteroviral Capsid Binder -
HY-106296
WIN 54954Antipicornavirus Agent -
HY-106161
RupintrivirHRV 3C Protease Inhibitor -
HY-104074
PocapavirCapsid Inhibitor -
HY-N2562
NorwogoninEnterovirus 71 Inhibitor -
HY-128382
Brilliant Black BNAntiviral Agent -
HY-19952R
Pleconaril (Standard)Capsid Inhibitor -
HY-N0306
Hederasaponin BAntiviral Agent -
HY-16561A
cis-ResveratrolEnteroviruses Inhibitor -
HY-N2036
MosloflavoneEV71 Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 107355-45-3
-
Peso molecular 383.27
-
Fòrmula C18H20Cl2N2O3
-
SMILES
ClC1=C(OCCCCCC2=CC(C)=NO2)C(Cl)=CC(C3=NCCO3)=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Woods MG, et, al. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother. 1989 Dec;33(12):2069-74. [Content Brief]
[2]. Fechner H, et, al. Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections. Molecules. 2011 Oct 11;16(10):8475-503. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
WIN 54954 (Standard) Related Classifications
HY-106296R Related Classifications
Powered by Bioz